Clinical Trial Update: Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Clinical Trial Update reports a Phase 2 study of Sunitinib in advanced non-clear cell renal cell carcinoma, specifically metastatic renal cell carcinoma, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sunitinib (sunitinib)

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN